Dr. Diane Merry, Ph.D
Bio
Dr. Diane Merry’s research focuses on the molecular mechanisms underlying inherited neurodegenerative disease, with a primary focus on Kennedy’s disease. Dr. Merry’s group has developed and utilizes unique cell and mouse models to both understand mechanisms of disease and identify molecular targets for therapeutic development. Over the past decades her group has investigated the structural and functional requirements of the mutant androgen receptor (AR) protein in disease and has identified several AR targets that are in preclinical development.
Dr. Merry serves as Vice Chair of the Department of Biochemistry and Molecular Biology at the Sidney Kimmel Medical College of Thomas Jefferson University and chairs the Scientific Advisory Board for the Vickie & Jack Farber Institute for Neuroscience at Jefferson.
